(Q36009890)

11 August 2017

1 reference

title

Zolpidem: a review of its use in the management of insomnia (English)

1 reference

11 August 2017

0 references

2

Gillian M Keating

1 reference

11 August 2017

author name string

Tracy Swainston Harrison

series ordinal

1

1 reference

11 August 2017

language of work or name

1 reference

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

volume

19

1 reference

11 August 2017

issue

1

1 reference

11 August 2017

page(s)

65-89

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200519010-00008

11 August 2017

exact match

0 references

cites work

Sleep Latency Is Shortened During 4 Weeks of Treatment With Zaleplon, a Novel Nonbenzodiazepine Hypnotic

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00023210-200519010-00008

[Safety profile of zolpidem: two studies of 3805 patients by Swiss practitioners]

21 January 2018

1 reference

12 December 2020

Evaluation of zolpidem on alertness and psychomotor abilities among aviation ground personnel and pilots.

1 reference

12 December 2020

A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia

1 reference

12 December 2020

Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem.

1 reference

12 December 2020

Insomnia: therapeutic approach

1 reference

12 December 2020

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation

1 reference

12 December 2020

Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance

1 reference

12 December 2020

Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.

1 reference

12 December 2020

Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening

1 reference

12 December 2020

Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.

1 reference

12 December 2020

Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions. A study of untreated unsomniacs

1 reference

12 December 2020

Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.

1 reference

12 December 2020

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data

1 reference

12 December 2020

A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening

1 reference

12 December 2020

Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal

1 reference

12 December 2020

Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.

1 reference

12 December 2020

Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia

1 reference

12 December 2020

Eight weeks of non-nightly use of zolpidem for primary insomnia.

1 reference

12 December 2020

Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies.

1 reference

12 December 2020

Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo

1 reference

12 December 2020

Gradual withdrawal of zopiclone (7.5 mg) and zolpidem (10 mg) in insomniacs treated for at least 3 months

1 reference

12 December 2020

Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on nocturnal cognitive performance in healthy subjects, in relation to pharmacokinetics.

1 reference

12 December 2020

Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.

1 reference

12 December 2020

Minimal rebound insomnia after treatment with 10-mg zolpidem

1 reference

12 December 2020

Consensus on drug treatment, definition and diagnosis for insomnia.

1 reference

12 December 2020

Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers.

1 reference

12 December 2020

Effects of daytime administration of zolpidem versus triazolam on memory

1 reference

12 December 2020

'As-needed' prescription of zolpidem for insomnia in routine general practice

1 reference

12 December 2020

The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium

1 reference

12 December 2020

Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases.

1 reference

12 December 2020

Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential

1 reference

12 December 2020

Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects

1 reference

12 December 2020

Residual effects of hypnotics on disengagement of spatial attention.

1 reference

12 December 2020

Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.

1 reference

12 December 2020

Zolpidem pharmacokinetic properties in young females: influence of smoking and oral contraceptive use.

1 reference

12 December 2020

Measuring outcomes in randomized clinical trials of insomnia treatments

1 reference

12 December 2020

"As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting

1 reference

12 December 2020

Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon

1 reference

12 December 2020

Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.

1 reference

12 December 2020

Residual effect of zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocular saccades

1 reference

12 December 2020

Consensus for the pharmacological management of insomnia in the new millennium

1 reference

12 December 2020

Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia

1 reference

12 December 2020

Comparative pharmacokinetics and pharmacodynamics of short-acting hypnosedatives: zaleplon, zolpidem and zopiclone

1 reference

12 December 2020

The effect of zolpidem and zopiclone on memory.

1 reference

12 December 2020

Long-term treatment of insomnia with zolpidem: a multicentre general practitioner study of 107 patients

1 reference

12 December 2020

Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers

1 reference

12 December 2020

Benzodiazepines and hip fractures in elderly people: case-control study

1 reference

12 December 2020

Comparative efficacy of zolpidem and temazepam in transient insomnia.

1 reference

12 December 2020

Comparison of the effects of zolpidem and triazolam on memory functions, psychomotor performances, and postural sway in healthy subjects.

1 reference

12 December 2020

Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice.

1 reference

12 December 2020

Clinically Important Drug Interactions with Zopiclone, Zolpidem and Zaleplon

1 reference

12 December 2020

Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients

1 reference

12 December 2020

Zolpidem in insomnia: a 3-year post-marketing surveillance study in Switzerland.

1 reference

12 December 2020

Amnesia possibly associated with zolpidem administration

1 reference

12 December 2020

Central nervous system side effects associated with zolpidem treatment

1 reference

12 December 2020

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group

1 reference

12 December 2020

Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.

1 reference

12 December 2020

Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study

1 reference

12 December 2020

Clinical and socioeconomic correlates of insomnia

1 reference

12 December 2020

A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials.

1 reference

12 December 2020

Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study

1 reference

12 December 2020

Hypnotic dependence: zolpidem and zopiclone too

1 reference

12 December 2020

Effects of daytime administration of zolpidem and triazolam on performance

1 reference

12 December 2020

Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study

1 reference

12 December 2020

The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice

1 reference

12 December 2020

Residual effects of hypnotics: epidemiology and clinical implications

1 reference

12 December 2020

Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.

1 reference

12 December 2020

Zolpidem for persistent insomnia in SSRI-treated depressed patients

1 reference

12 December 2020

Zolpidem use and hip fractures in older people

1 reference

12 December 2020

Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers.

1 reference

12 December 2020

The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance.

1 reference

12 December 2020

Residual effects of sleep medication on driving ability

1 reference

12 December 2020

A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.

1 reference

12 December 2020

10.2165/00023210-200519010-00008

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1028138213

0 references

1 reference